At the Magee-Womens Heart Program, part of the UPMC Heart and Vascular Institute, we know that women’s hearts are different from men’s, and that heart disease can cause different symptoms in both women and men.
We understand these differences and are dedicated to helping all of our patients overcome heart problems. Both women and men can be referred to the Magee-Womens Heart Program.
Knowing the facts about heart disease can prevent disability and even death. Regardless of your gender, a key to combating heart disease is early and accurate detection.
Our comprehensive diagnostic cardiology testing services help detect heart-related illnesses. The highly-trained physicians at the Magee-Womens Heart Program will then meet with you and interpret your test results.
Cardiac diagnostics can go a long way in helping to fight heart disease, but education is also a key to overcoming this problem.
The Magee-Womens Heart Program also focuses on patient education. The nurse manager, nuclear medicine technologist, registered nurse, echocardiographer, and medical assistants take time to discuss your concerns.
Monday through Friday
8 a.m. to 4:30 p.m.
If you would like more information about the Magee-Womens Heart Program, part of the UPMC Heart and Vascular Institute, or want to schedule an appointment, call
Preeclampsia is a condition that can affect any woman who is pregnant or has recently delivered her baby. This condition is characterized by high blood pressure and protein in the urine. Please join us for a Preeclampsia Awareness class to learn more about the risk factors and management of this disorder. This class will be held on Feb. 27 from 6 to 7 p.m. at UPMC Magee-Womens Hospital in Pittsburgh and virtually via Microsoft Teams.
We offer risk assessments that evaluate your lifestyle, medical history, and family history.
We also offer diagnostic services, including:
Certain treatment options may be given to you, such as:
We offer convenient cardiac care with both on-site cardiologists and cardiac testing services. Our team of physicians is available five days a week to meet with patients and interpret test results. If testing shows that invasive treatment is necessary, patients are referred to other UPMC Heart and Vascular Institute locations for treatment.
The purpose of REBIRTH is to test whether drug called bromocriptine can strengthen the heart in women diagnosed with peripartum cardiomyopathy when compared to those not taking the drug while all remain on heart failure medication. Women who breastfeed may be eligible to be in an observational group that does not take study drug.
Site PI: Agnes Koczo, MD
The goal of the iSCAD Registry is to facilitate the development of best practices and clinical guidelines for predicting and treating SCAD as well as preventing its recurrence. This survey-based observational study is recruiting participating with recent or remote history of SCAD. Interested patients can be referred to the SCAD Clinic at the Magee Women’s Cardiovascular Center for enrollment in the registry.
Participants must be:
This research study aims to show why women have these abnormal heart muscle changes in the 10 to 12 years after having their babies. To do this, we will use heart MRI and blood measurements. Heart MRI gives a more in-depth look at the heart muscle and blood measurements will identify the number of proteins and molecules in the blood to understand if these molecules contribute to the heart muscle changes found on heart MRI.
This proposed study aligns directly with the mission of the American Heart Association to help women live healthier lives and prevent heart disease.
Cardiovascular disease (CVD) is the leading cause of death for women, yet CVD mortality rates among young women remain alarmingly stagnant. Women with a history of hypertensive disorders of pregnancy (HDP) are at an increased risk for CVD compared with women who have uncomplicated pregnancies.
The purpose of this study is to develop a database to study postpartum women with a history of pregnancy complications including high blood pressure, hypertension, preeclampsia, and gestational hypertension. This study will allow us to collect data on women in the postpartum period who attend a postpartum hypertension clinic to guide best practices.
All patients in the Postpartum Hypertension Clinic older than 18 will be asked to complete a questionnaire on their medical history, demographic information, pregnancy history, symptoms, and knowledge about hypertensive disorders of pregnancy. These questionnaires will be used to build a database to study women with a history of hypertensive disorders of pregnancy. Participants who complete the survey will receive a $10 Amazon gift card (delivered electronically).
Participants must be above the age of 18 and have a diagnosis of a pregnancy complication including chronic hypertension, gestational diabetes, gestational hypertension, preeclampsia, heart failure, or peripartum cardiomyopathy.